Statin use was linked to improved OS (HR, 0.77; 95% CI, 0.72–0.82; p < 0.001), as were other factors like aspirin, metformin, SGLT-2 inhibitors, sulfonylurea use, and a history of HTN and cardiovascular disease. Here, SLC5A2 is linked to cardiovascular disorder.